Devereaux PJ, Biccard Bm, Sigamani A, et al. Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery[J]. JAMA, 2017, 317(16): 1642-1651.

Wang HQ, Lei JG. Comparison of risk assessment systems for perioperative cardiovascular events in non-cardiac surgery[J]. Adv Cardiovasc Dis, 2021, 42(8): 720-724.

王惠琴, 雷建国. 非心脏手术围手术期心血管事件风险评估体系比较[J]. 心血管病学进展, 2021, 42(8): 720-724.

Halvorsen S, Mehilli J, Cassese S, et al. 2022 ESC Guidelines on cardiovascular assessment and management of patients undergoing non-cardiac surgery[J]. Eur Heart J, 2022, 43(39): 3826-3924.

Ning JZ. Key data from the Seventh National Census[J]. China Statistics, 2021, 5: 4-5.

宁吉喆. 第七次全国人口普查主要数据情况[J]. 中国统计, 2021, (5): 4-5.

Kristensen SD, Knuuti J, Saraste A, et al. 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: the Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA)[J]. Eur Heart J, 2014, 35(35): 2383-2431.

Wijeysundera DN, Pearse RM, Shulman MA, et al. Assessment of functional capacity before major non-cardiac surgery: an international, prospective cohort study[J]. Lancet, 2018, 391(10140): 2631-2640.

Wijeysundera DN, Beattie WS, Hillis GS, et al. Integration of the Duke Activity Status Index into preoperative risk evaluation: a multicentre prospective cohort study[J]. Br J Anaesth, 2020, 124(3): 261-270.

Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery[J]. Circulation, 1999, 100(10): 1043-1049.

Gupta PK, Gupta H, Sundaram A, et al. Development and validation of a risk calculator for prediction of cardiac risk after surgery[J]. Circulation, 2011, 124(4): 381-387.

Bilimoria KY, Liu Y, Paruch JL, et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons[J]. J Am Coll Surg, 2013, 217(5): 833-842. e1-3.

Alrezk R, Jackson N, Al Rezk M, et al. Derivation and validation of a geriatric-sensitive perioperative cardiac risk index[J]. J Am Heart Assoc, 2017, 6(11): e006648.

Zhao M, Shang Z, Cai J, et al. Development and validation of predictive model-HASBLAD score-for major adverse cardiovascular events during perioperative period of non-cardiac surgery: a single center experience in China[J]. Front Cardiovasc Med, 2022, 9: 774191.

Zhang K, Liu C, Sha X, et al. Development and validation of a prediction model to predict major adverse cardiovascular events in elderly patients undergoing noncardiac surgery: a retrospective cohort study[J]. Atherosclerosis, 2023, 376: 71-79.

Oh AR, Park J, Shin SJ, et al. Prediction model for myocardial injury after non-cardiac surgery using machine learning[J]. Sci Rep, 2023, 13(1): 1475.

Shin SJ, Park J, Lee SH, et al. Predictability of mortality in patients with myocardial injury after noncardiac surgery based on perioperative factors via machine learning: retrospective study[J]. JMIR Med Inform, 2021, 9(10): e32771.

Rodseth RN, Biccard BM, le Manach Y, et al. The prognostic value of pre-operative and post-operative B-type natriuretic peptides in patients undergoing noncardiac surgery: B-type natriuretic peptide and N-terminal fragment of pro-B-type natriuretic peptide: a systematic review and individual patient data meta-analysis[J]. J Am Coll Cardiol, 2014, 63(2): 170-180.

Duceppe E, Parlow J, MacDonald P, et al. Canadian cardiovascular society guidelines on perioperative cardiac risk assessment and management for patients who undergo noncardiac surgery[J]. Can J Cardiol, 2017, 33(1): 17-32.

Duceppe E, Patel A, Chan MTV, et al. Preoperative N-terminal pro-B-type natriuretic peptide and cardiovascular events after noncardiac surgery: a cohort study[J]. Ann Intern Med, 2020, 172(2): 96-104.

Zhang K, Liu C, Tan J, et al. Using preoperative N-terminal pro-B-type natriuretic peptide levels for predicting major adverse cardiovascular events and myocardial injury after noncardiac surgery in Chinese advanced-age patients[J]. J Geriatr Cardiol, 2022, 19(10): 768-779.

Maile MD, Jewell ES, Engoren MC. Timing of preoperative troponin elevations and postoperative mortality after noncardiac surgery[J]. Anesth Analg, 2016, 123(1): 135-140.

Fleisher LA, Fleischmann KE, Auerbach AD, et al. 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines[J]. Circulation, 2014, 130(24): 2215-2245.

Jia RB, Liu HT, Geng WZ. Combined application of troponin T and N-terminal B-type natriuretic peptidogen for the prediction of perioperative cardiovascular events in elderly patients with coronary artery disease undergoing non-cardiac surgery[J]. Chin Circul J, 2015, 30(9): 837-840.

贾荣波, 刘海涛, 耿文真. 联合应用肌钙蛋白T和N末端B型利钠肽原对老年冠心病患者非心脏手术围手术期心血管事件的预测[J]. 中国循环杂志, 2015, 30(9): 837-840.

Larmann J, Handke J, Scholz AS, et al. Preoperative neutrophil to lymphocyte ratio and platelet to lymphocyte ratio are associated with major adverse cardiovascular and cerebrovascular events in coronary heart disease patients undergoing non-cardiac surgery[J]. BMC Cardiovasc Disord, 2020, 20(1): 230.

Wen Y, Wang P, Zhao R, The predictive value of preoperative neutrophil lymphocyte ratio and platelet lymphocyte ratio for cardiovascular events in elderly patients with coronary artery disease after non-cardiac surgery[J]. Chin J Gerontol, 2022, 42(3): 513-516.

闻勇, 王鹏, 赵韧. 术前中性粒细胞淋巴细胞比值和血小板淋巴细胞比值对老年冠心病患者非心脏术后心血管事件的预测价值[J]. 中国老年学杂志, 2022, 42(3): 513-516.

Salvagno GL, Sanchis-Gomar F, Picanza A, et al. Red blood cell distribution width: A simple parameter with multiple clinical applications[J]. Crit Rev Clin Lab Sci, 2015, 52(2): 86-105.

Dabbah S, Hammerman H, Markiewicz W, et al. Relation between red cell distribution width and clinical outcomes after acute myocardial infarction[J]. Am J Cardiol, 2010, 105(3): 312-317.

Liu C, Zhang K, Zhang T, et al. Higher preoperative red blood cell distribution width increases the risk of myocardial injury after noncardiac surgery in advanced-age patients: a retrospective cohort study[J]. Clin Interv Aging, 2023, 18: 169-179.

Mases A, Sabaté S, Guilera N, et al. Preoperative estimated glomerular filtration rate and the risk of major adverse cardiovascular and cerebrovascular events in non-cardiac surgery[J]. Br J Anaesth, 2014, 113(4): 644-651.

Warren JA, George J, Anis HK, et al. Effects of estimated glomerular filtration rate on 30-day mortality and postoperative complications after total hip arthroplasty: a risk stratification instrument[J]. J Arthroplasty, 2020, 35(3): 786-793.

Krebs OK, Warren JA, Anis HK, et al. Estimated glomerular filtration rate as a risk stratification tool for early complications in revision total hip and knee arthroplasty[J]. J Arthroplasty, 2020, 35(5): 1315-1322.

Sundaram K, Warren JA, Krebs OK, et al. Estimated glomerular filtration rate is a prognosticator of adverse outcomes after primary total knee arthroplasty among patients with chronic kidney disease and glomerular hyperfiltration[J]. Knee, 2021, 28: 36-44.

Wesselink EM, Kappen TH, Torn HM, et al. Intraoperative hypotension and the risk of postoperative adverse outcomes: a systematic review[J]. Br J Anaesth, 2018, 121(4): 706-721.

Bijker JB, van Klei WA, Kappen TH, et al. Incidence of intraoperative hypotension as a function of the chosen definition: literature definitions applied to a retrospective cohort using automated data collection[J]. Anesthesiology, 2007, 107(2): 213-220.

Futier E, Lefrant JY, Guinot PG, et al. Effect of individualized vs standard blood pressure management strategies on postoperative organ dysfunction among high-risk patients undergoing major surgery: a randomized clinical trial[J]. JAMA, 2017, 318(14): 1346-1357.

Reich DL, Bennett-Guerrero E, Bodian CA, et al. Intraoperative tachycardia and hypertension are independently associated with adverse outcome in noncardiac surgery of long duration[J]. Anesth Analg, 2002, 95(2): 273-277, table of contents.

Shimada T, Mascha EJ, Yang D, et al. Intra-operative hypertension and myocardial injury and/or mortality and acute kidney injury after noncardiac surgery: a retrospective cohort analysis[J]. Eur J Anaesthesiol, 2022, 39(4): 315-323.

Arulkumaran N, Corredor C, Hamilton MA, et al. Cardiac complications associated with goal-directed therapy in high-risk surgical patients: a meta-analysis[J]. Br J Anaesth, 2014, 112(4): 648-659.

Nicklas JY, Diener O, Leistenschneider M, et al. Personalised haemodynamic management targeting baseline cardiac index in high-risk patients undergoing major abdominal surgery: a randomised single-centre clinical trial[J]. Br J Anaesth, 2020, 125(2): 122-132.

Wang M, Yang Y, Zhang KY, et al. Effect of intraoperative goal-directed fluid therapy on postoperative rehabilitation of patients undergoing laparoscopic gastric sleeve resection[J]. J Jiangsu Univ (Med Ed), 2022, 32(5): 439-443, 451

汪敏, 杨奕, 张克尧, 等. 术中目标导向液体治疗对腹腔镜胃袖状切除术患者术后康复的影响[J]. 江苏大学学报(医学版), 2022, 32(5): 439-443, 451.

Kouz K, Bergholz A, Diener O, et al. Effect of intraoperative personalized goal-directed hemodynamic management on acute myocardial injury in high-risk patients having major abdominal surgery: a post-hoc secondary analysis of a randomized clinical trial[J]. J Clin Monit Comput, 2022, 36(6): 1775-1783.

Frank SM, Fleisher LA, Breslow MJ, et al. Perioperative maintenance of normothermia reduces the incidence of morbid cardiac events. a randomized clinical trial[J]. JAMA, 1997, 277(14): 1127-1134.

Schacham YN, Cohen B, Bajracharya GR, et al. Mild perioperative hypothermia and myocardial injury: a retrospective cohort analysis[J]. Anesth Analg, 2018, 127(6): 1335-1341.

Straarup TS, Hausenloy DJ, Rolighed Larsen JK. Cardiac troponins and volatile anaesthetics in coronary artery bypass graft surgery: a systematic review, meta-analysis and trial sequential analysis[J]. Eur J Anaesthesiol, 2016, 33(6): 396-407.

Landoni G, Lomivorotov VV, Nigro Neto C, et al. Volatile anesthetics versus total Intravenous anesthesia for cardiac surgery[J]. N Engl J Med, 2019, 380(13): 1214-1225.

Lurati Buse GAL, Schumacher P, Seeberger E, et al. Randomized comparison of sevoflurane versus propofol to reduce perioperative myocardial ischemia in patients undergoing noncardiac surgery[J]. Circulation, 2012, 126(23): 2696-2704.

Shaydenfish D, Scheffenbichler FT, Kelly BJ, et al. Effects of anticholinesterase reversal under general anesthesia on postoperative cardiovascular complications: a retrospective cohort study[J]. Anesth Analg, 2020, 130(3): 685-695.

Devereaux PJ, Mrkobrada M, Sessler DI, et al. Aspirin in patients undergoing noncardiac surgery[J]. N Engl J Med, 2014, 370(16): 1494-1503.

Graham MM, Sessler DI, Parlow JL, et al. Aspirin in patients with previous percutaneous coronary intervention undergoing noncardiac surgery[J]. Ann Intern Med, 2018, 168(4): 237-244.

Siller-Matula JM, Petre A, Delle-Karth G, et al. Impact of preoperative use of P2Y12 receptor inhibitors on clinical outcomes in cardiac and non-cardiac surgery: a systematic review and meta-analysis[J]. Eur Heart J Acute Cardiovasc Care, 2017, 6(8): 753-770.

Mehran R, Baber U, Steg PG, et al. Cessation of dual antiplatelet treatment and cardiac events after percutaneous coronary intervention (PARIS): 2 year results from a prospective observational study[J]. Lancet, 2013, 382(9906): 1714-1722.

Devereaux PJ, Duceppe E, Guyatt G, et al. Dabigatran in patients with myocardial injury after non-cardiac surgery (MANAGE): an international, randomised, placebo-controlled trial[J]. Lancet, 2018, 391(10137): 2325-2334.

Clemente-Moragón A, Gómez M, Villena-Gutiérrez R, et al. Metoprolol exerts a non-class effect against ischaemia-reperfusion injury by abrogating exacerbated inflammation[J]. Eur Heart J, 2020, 41(46): 4425-4440.

Devereaux PJ, Yang H, Yusuf S, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomised controlled trial[J]. Lancet, 2008, 371(9627): 1839-1847.

Kertai MD, Cooter M, Pollard RJ, et al. Is compliance with surgical care improvement project cardiac (SCIP-Card-2) measures for perioperative β-blockers associated with reduced incidence of mortality and cardiovascular-related critical quality indicators after noncardiac surgery?[J]. Anesth Analg, 2018, 126(6): 1829-1838.

Hollmann C, Fernandes NL, Biccard BM. A systematic review of outcomes associated with withholding or continuing angiotensin-converting enzyme inhibitors and angiotensin receptor blockers before noncardiac surgery[J]. Anesth Analg, 2018, 127(3): 678-687.

Roshanov PS, Rochwerg B, Patel A, et al. Withholding versus continuing angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers before noncardiac surgery: an analysis of the vascular events in noncardiac surgery patients cohort evaluation prospective cohort[J]. Anesthesiology, 2017, 126(1): 16-27.

London MJ, Schwartz GG, Hur K, et al. Association of perioperative statin use with mortality and morbidity after major noncardiac surgery[J]. JAMA Intern Med, 2017, 177(2): 231-242.

Lindenauer PK, Pekow P, Wang K, et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery[J]. JAMA, 2004, 291(17): 2092-2099.

Berwanger O, de Barros ESPG, Barbosa RR, et al. Atorvastatin for high-risk statin-naïve patients undergoing noncardiac surgery: the lowering the risk of operative complications using atorvastatin loading dose (LOAD) randomized trial[J]. Am Heart J, 2017, 184: 88-96.